Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Leukemia & Lymphoma|June 1, 1997
Taxol pretreatment of tumor targets amplifies natural killer cell mediated lysisS Mehta, D Blackinton, M Manfredi, et al.Journal of Surgical Oncology|September 1, 1994
Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanomaD Shrayer, H Bogaars, D Gersten, et al.Surgery|September 1, 1989
The influence of the surgical wound on local tumor recurrenceD G Baker, T M Masterson, R Pace, et al.Cancer|February 1, 1982
The influence of warfarin of levamisole on the incidence of metastases following local irradiation of a solid tumorD Baker, D Elkon, M L Lim, et al.Cancer Chemotherapy and Pharmacology|September 6, 2000
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell lineS Mehta, D Blackinton, I Omar, et al.Leukemia Research|June 22, 1999
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramideD Myrick, D Blackinton, J Klostergaard, et al.Pigment Cell Research|September 1, 1992
B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigensD Shrayer, D M Gersten, J Koness, et al.International Journal of Oncology|May 14, 2011
Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma modelD Shrayer, J Koness, N Kouttab, et al.International Journal of Cancer|February 20, 1993
Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccineD Shrayer, N Kouttab, A Maizel, et al.The American Surgeon|March 1, 1986
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO)M K Wallack, K McNally, M Michaelides, et al.Pageof 4